Dianxianning improved amyloid β-induced pathological characteristics partially through DAF-2/DAF-16 insulin like pathway in transgenic C. Elegans

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Zhi, Dejuan ^a   Wang, Dong ^a   Yang, Wenqi ^a   Duan, Ziyun ^a   Zhu, Shuqian ^a   Dong, Juan ^a   Wang, Na ^a   Wang, Ningbo ^a   Fei, Dongqing ^a   Zhang, Zhanxin ^a   Wang, Xin ^a   Wang, Meizhu ^a   Li, Hongyu ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; CAENORHABDITIS ELEGANS PROTEIN; DAF-16 PROTEIN, C ELEGANS; DAF-2 PROTEIN, C ELEGANS; FORKHEAD TRANSCRIPTION FACTOR; HERBACEOUS AGENT; INSULIN RECEPTOR; PROTEIN AGGREGATE;

ALZHEIMER DISEASE; ANIMAL; BIOLOGICAL MODEL; CAENORHABDITIS ELEGANS; CHEMICAL STRUCTURE; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; GENETICS; MAZE TEST; METABOLISM; PATHOLOGY; PROTEIN MULTIMERIZATION; PROTEINOSIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOMARKERS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; MAZE LEARNING; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; PROTEIN AGGREGATES; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN MULTIMERIZATION; RECEPTOR, INSULIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 85029382976     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-11628-9     Document Type: Article

References (62)

1. Hou, Y. J. et al. Smart soup, a traditional Chinese medicine formula, ameliorates amyloid pathology and related cognitive deficits. PloS one 9(11), e111215 (2014).
2. Prince, M. et al. World Alzheimer Report 2015. The global impact of dementia. An analysis of prevalence, incidence, cost and trends. Alzheimer's disease international, London (2015).
3. Blennow, K., de Leon, M. J. & Zetterberg, H. Alzheimer's disease. Lancet 368, 387-403 (2006).
4. Mucke, L. Neuroscience: Alzheimer's disease. Nature 461, 895-897 (2009).
5. Golde, T. E., Petrucelli, L. & Lewis, J. Targeting Abeta and tau in Alzheimer's disease, an early interim report. Exp. Neurol. 223, 252-266 (2010).
6. Sanchez, P. E. et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proc Natl Acad Sci USA 109, E2895-E2903 (2012).
7. Bica, L., Crouch, P. J., Cappai, R. & White, A. R. Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease. Mol. BioSyst. 5, 134-142 (2009).
8. Vossel, K. A. et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 70, 1158-1166 (2013).
9. Palop, J. J. & Mucke, L. Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin? Neuromol. Med. 12, 48-55 (2010).
10. Zhang, M. Y. et al. Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP/PS1 transgenic mice. Neurobiol. Aging 35, 2713-2725 (2014).
11. Kwan, P. & Brodie, M. J. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 357, 216-222 (2001).
12. Qing, H. et al. Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J. Exp. Med. 205, 2781-2789 (2008).
13. He, L. et al. Reevaluation of the effect of Dianxianning on seizure rate of refractory epilepsy as additive treatment in clinical practice. Front. Med. 5, 229-234 (2011).
14. Jugran, A. et al. Association of ISSR markers with some biochemical traits of Valeriana jatamansi Jones. Ind. Crop. Prod. 44, 671-676 (2013).
15. You, J. S. et al. Evaluation of anxiolytic activity of compound Valeriana jatamansi Jones in mice. BMC Complem. Altern. Med. 12, 1 (2012).
16. Fujiwara, H. et al. Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's beta-amyloid proteins. J. Neurosci. Res. 84, 427-433 (2006).
17. Xian, Y. F. et al. Bioassay-guided isolation of neuroprotective compounds from Uncaria rhynchophylla against beta-amyloid-induced neurotoxicity. Evid-Based Compl. Alternat. Med. 2012 (2012).
18. Link, C. D. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 92, 9368-9372 (1995).
19. Brown, M. K. & Luo, Y. Bilobalide modulates serotonin-controlled behaviors in the nematode Caenorhabditis elegans. BMC Neurosci. 10, 1 (2009).
20. Nuttley, W. M., Atkinson-Leadbeater, K. P. & Van Der Kooy, D. Serotonin mediates food-odor associative learning in the nematode Caenorhabditis elegans. Proc Natl Acad Sci USA 99, 12449-12454 (2002).
21. Sawin, E. R., Ranganathan, R. & Horvitz, H. R. C. Elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron 26, 619-631 (2000).
22. Wu, Y. et al. Amyloid-β-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J. Neurosci. 26, 13102-13113 (2006).
23. Arya, U., Dwivedi, H. & Subramaniam, J. R. Reserpine ameliorates Aβ toxicity in the Alzheimer's disease model in Caenorhabditis elegans. Exp. Gerontol. 44, 462-466 (2009).
24. Wesnes, K. A. et al. Cholinesterase inhibition in the scopolamine model of dementia. Ann. NY Acad. Sci. 640(1), 268-271 (1991).
25. Xu, J. et al. Iridoids from the roots of Valeriana jatamansi and their neuroprotective effects. Fitoterapia 82, 1133-1136 (2011).
26. Shukla, V. et al. Iridoid compound 10-O-trans-p-coumaroylcatalpol extends longevity and reduces alpha synuclein aggregation in Caenorhabditis elegans. CNS Neurol. Disord-DR. 11(8), 984-992 (2012).
27. Scholtzova, H., Wadghiri, Y. Z. & Douadi, M. et al. Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging. J. Neurosci. Res. 86(12), 2784-2791 (2008).
28. Alley, G. M., Bailey, J. A. & Chen, D. M. et al. Memantine lowers amyloid-β peptide levels in neuronal cultures and in APP/PS1 transgenic mice. J. Neurosci. Res. 88(1), 143-154 (2010).
29. Martinez-Coria, H., Green, K. N. & Billings, L. M. et al. Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice. Am. J. Pathol. 176(2), 870-880 (2010).
30. Liu, M. Y., Wang, S. & Yao, W. F. et al. Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice. Neurosci. 273, 141-151 (2014).
31. Lacor, P. N. et al. Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 27, 796-807 (2007).
32. Lesné, S. et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357 (2006).
33. Murphy, C. T. & Hu, P. J. Insulin/insulin-like growth factor signaling in C. Elegans, WormBook, ed. The C. Elegans Research Community, WormBook, doi/10.1895/wormbook.1.164.1, http://www.wormbook.org (2013).
34. Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W. & Dillin, A. Opposing activities protect against age-onset proteotoxicity. Science 313, 1604-1610 (2006).
35. Fonte, V. et al. Suppression of in vivo β-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein. J. Biol. Chem. 283, 784-791 (2008).
36. Back, P., Matthijssens, F., Vlaeminck, C., Braeckman, B. P. & Vanfleteren, J. R. Effects of sod gene overexpression and deletion mutation on the expression profiles of reporter genes of major detoxification pathways in Caenorhabditis elegans. Exp. Gerontol. 45(7), 603-610 (2010).
37. Leroux, M. R., Melki, R., Gordon, B., Batelier, G. & Candido, E. P. Structurefunction studies on small heat shock protein oligomeric assembly and interaction with unfolded polypeptides. J. Biol. Chem. 272, 24646-24656 (1997).
38. Morley, J. F. & Morimoto, R. I. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol. Biol. Cell 15, 657-664 (2004).
39. Dong, F. et al. Iridoids and sesquiterpenoids of Valeriana stenoptera and their effects on NGF-induced neurite outgrowth in PC12 cells. Phytochemistry 118, 51-60 (2015).
40. Golde, T. E., Schneider, L. S. & Koo, E. H. Anti-Aβ therapeutics in Alzheimer's disease: the need for a paradigm shift. Neuron 69, 203-213 (2011).
41. Cuevas, M. E. et al. Soluble Aβ1-40 Peptide Increases Excitatory Neurotransmission and Induces Epileptiform Activity in Hippocampal Neurons. J. Alzheimers Dis. 23, 673-687 (2011).
42. Sakono, M. & Zako, T. Amyloid oligomers: formation and toxicity of Aβ oligomers. FEBS J. 277, 1348-1358 (2010).
43. Kim, K. K., Kim, R. & Kim, S. H. Crystal structure of a small heat-shock protein. Nature 394, 595-599 (1998).
44. Edwards, H. V., Cameron, R. T. & Baillie, G. S. The emerging role of HSP20 as a multifunctional protective agent. Cell. Signal. 23, 1447-1454 (2011).
45. Heidler, T., Hartwig, K., Daniel, H. & Wenzel, U. Caenorhabditis elegans lifespan extension caused by treatment with an orally active ROS-generator is dependent on DAF-16 and SIR-2.1. Biogerontology 11, 183-195 (2010).
46. Prasad, R. et al. Valeriana jatamansi partially reverses liver cirrhosis and tissue hyperproliferative response in rat. Method. Find. Exp. Clin. 32, 713 (2010).
47. Zhang, W. et al. Characterization of polysaccharides with antioxidant and immunological activities from Rhizoma Acori Tatarinowii. Carbohyd. Polym. 133, 154-162 (2015).
48. Minniti, A. N. et al. The protein oxidation repair enzyme methionine sulfoxide reductase a modulates Aβ aggregation and toxicity in vivo. Antioxid. Redox Sig. 22, 48-62 (2015).
49. Wolkow, C. A., Kimura, K. D., Lee, M. S. & Ruvkun, G. Regulation of C. Elegans life-span by insulinlike signaling in the nervous system. Science 290, 147-150 (2000).
50. Chauhan, V. & Chauhan, A. Oxidative stress in Alzheimer's disease. Pathophysiol 13, 195-208 (2006).
51. Chávez, V., Mohri-Shiomi, A., Maadani, A., Vega, L. A. & Garsin, D. A. Oxidative stress enzymes are required for DAF-16-mediated immunity due to generation of reactive oxygen species by Caenorhabditis elegans. Genetics 176, 1567-1577 (2007).
52. McElwee, J., Bubb, K. & Thomas, J. H. Transcriptional outputs of the Caenorhabditis elegans forkhead protein DAF-16. Aging Cell 2, 111-121 (2003).
53. Chen, X. et al. Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression. Mol. Neurodegene 10, 1-14 (2015).
54. Hsu, A. L., Murphy, C. T. & Kenyon, C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 300, 1142-1145 (2003).
55. Tullet, J. M. A. et al. Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. Elegans. Cell 132, 1025-1038 (2008).
56. Di, H. et al. Determination of valtrate, acevaltrate, and their degradation product-baldrinal in Valeriana wallichii by HPLC analysis. Chinese Tradit. Herb. Drugs 12, 046 (2007).
57. Li, P. et al. Content determination of total iridoid compounds and baldrinal and 11-ethoxyviburtinal from Valerianae Jatamansi Rhizoma et Radix. Chinese J. Inform. Tradit. Chinese Med. 88-91 (2016).
58. Dostal, V., Roberts, C. M. & Link, C. D. Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of β-amyloid peptide toxicity. Genetics 186, 857-866 (2010).
59. Henderson, S. T. & Johnson, T. E. Daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr. Biol. 11, 1975-1980 (2001).
60. Fraser, A. G. et al. Functional genomic analysis of C. Elegans chromosome I by systematic RNA interference. Nature 408, 325-330 (2000).
61. Keowkase, R., Aboukhatwa, M. & Luo, Y. Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans. Neuropharmacology 59, 358-365 (2010).
62. Morris, R. G. M. Spatial localization does not require the presence of local cues. Learn. Motiv. 12, 239-260 (1981).